Jefferies Downgrades NGM Biopharmaceuticals (NGM) to Hold

October 17, 2022 11:46 AM EDT
Get Alerts NGM Hot Sheet
Price: $5.21 -0.57%

Rating Summary:
    7 Buy, 3 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 32 | New: 11
Join SI Premium – FREE

Jefferies analyst Dennis Ding downgraded NGM Biopharmaceuticals (NASDAQ: NGM) from Buy to Hold with a price target of $4.00 (from $25.00).

For an analyst ratings summary and ratings history on NGM Biopharmaceuticals click here. For more ratings news on NGM Biopharmaceuticals click here.

Shares of NGM Biopharmaceuticals closed at $11.55 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades